Source comparison
Quickcomparison
Dose Range IGF-1 LR3 20–100 mcg Human Growth Hormone (HGH) 1–4 IU Frequency Once daily Administration Subcutaneous injection Cycle Length 4-6 weeks 12+ weeks Onset Speed Rapid (hours to days) Gradual (3-4 weeks) Evidence Level Strong preclinical (extensive ani
This comparison does not assign a generated winner or score.
- Dose Range
- IGF-1 LR3
- 20–100 mcg
- Human Growth Hormone (HGH)
- 1–4 IU
- Frequency
- Once daily
- Administration
- Subcutaneous injection
- Cycle Length
- 4-6 weeks
- 12+ weeks
- Onset Speed
- Rapid (hours to days)
- Gradual (3-4 weeks)
- Evidence Level
- Strong preclinical (extensive animal studies)
- Strong human trials (Phase 3 or FDA approved)
- Efficacy